We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Early Differences in Cytokine Production Distinguish Severity of COVID-19

By LabMedica International staff writers
Posted on 27 Jan 2021
Print article
Image: The Bio-Plex Pro Human Cytokine Screening 48-plex panel (Photo courtesy of Bio-Rad Laboratories).
Image: The Bio-Plex Pro Human Cytokine Screening 48-plex panel (Photo courtesy of Bio-Rad Laboratories).
Most COVID-19 patients experience asymptomatic/mild symptoms, but some suffer critical symptoms requiring intensive care. It is important to determine how asymptomatic/mild patients react to SARS-CoV-2 infection and suppress virus spread.

It has been shown that several components of the immune response are dysregulated in COVID-19 patients with severe symptoms. Monocytes and macrophages were significantly dysregulated in severe patients. Dendritic cells and natural killer (NK) cells were depleted in COVID-19 patients compared to healthy controls, and it has been determined that those cells are dysregulated in the setting of SARS-CoV-2 infection.

A team of Clinical Virologists at the Kobe University Graduate School of Medicine (Kobe, Japan) analyzed cytokines induced by the innate immune response in 95 COVID-19 patients (median age, 50 years; 55% male) with different disease severities during their early phase of infection, less than 10 days after symptom onset or after an asymptomatic patient being notified of contact with a positive case. Of the patients, 16 were asymptomatic, 49 had mild disease, 11 had moderate disease, and 19 had severe disease.

The diagnosis of COVID-19 was determined by the detection of SARS-CoV-2 genome in a nasopharyngeal swab sample by polymerase chain reaction (PCR). Serum samples were subjected to the measurements of cytokines, chemokines, and growth factor (CCG) with the Bio-Plex Pro Human Cytokine Screening 48-plex panel (Bio-Rad Laboratories, Hercules, CA, USA) and the results were read using the Bio-Plex 200 system.

The team reported that IL-12 level was significantly higher in both the asymptomatic group and the mild group compared to the moderate and severe groups. Similarly, serum level of IL-2 was found to be significantly higher in the asymptomatic and mild COVID-19 patients compared with moderate and severe patients. Meanwhile, serum level of IL-18 was significantly higher in the symptomatic COVID-19 patients compared with asymptomatic patients and healthy controls. Similarly, the team found that IL-6 level increased with the severity level of COVID-19 in the acute phase. The investigators noted that IL-2 is also known as a growth factor for NK cells and has a synergistic effect with IL-18 to enhance the cytotoxicity and expansion of NK cells.

The authors concluded that their investigation was the first to show that during the acute phase of infection, significantly higher levels of IL-12 and IL-2 were induced in COVID-19 patients with asymptomatic and mild symptoms compared to those with moderate and severe symptoms, indicating the important roles of these two cytokines in the protection from severe COVID19. The study was published on January 7, 2021 in the Journal of Infectious Diseases.

Related Links:
Kobe University Graduate School of Medicine
Bio-Rad Laboratories


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.